Your browser doesn't support javascript.
loading
Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes.
Massalou, Damien; Benizri, Emmanuel; Chevallier, Anne; Duranton-Tanneur, Valérie; Pedeutour, Florence; Benchimol, Daniel; Béréder, Jean-Marc.
Afiliação
  • Massalou D; Department of General Surgery and Digestive Cancerology, Nice University Hospital, 151 route de St. Antoine de Ginestière, Nice, 06200, France; Acute Care Surgery Unit, Emergency Department and Intensive Care, Nice University Hospital, University of Nice Sophia-Antipolis, Nice, France.
  • Benizri E; Department of General Surgery and Digestive Cancerology, Nice University Hospital, 151 route de St. Antoine de Ginestière, Nice, 06200, France. Electronic address: benizri.e@chu-nice.fr.
  • Chevallier A; Central Laboratory of Pathology, Laboratory Department, Nice University Hospital, University of Nice Sophia-Antipolis, Nice, France.
  • Duranton-Tanneur V; Laboratory of Solid Tumor Genetics, Laboratory Department, Nice University Hospital, University of Nice Sophia-Antipolis, Nice, France.
  • Pedeutour F; Laboratory of Solid Tumor Genetics, Laboratory Department, Nice University Hospital, University of Nice Sophia-Antipolis, Nice, France.
  • Benchimol D; Department of General Surgery and Digestive Cancerology, Nice University Hospital, 151 route de St. Antoine de Ginestière, Nice, 06200, France.
  • Béréder JM; Department of General Surgery and Digestive Cancerology, Nice University Hospital, 151 route de St. Antoine de Ginestière, Nice, 06200, France.
Am J Surg ; 213(2): 377-387, 2017 Feb.
Article em En | MEDLINE | ID: mdl-27816197
ABSTRACT

BACKGROUND:

The objective of this study was to identify the prognostic impact of parameters in peritoneal carcinomatosis from colorectal cancer.

METHODS:

We collected data from patients treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy for peritoneal carcinomatosis secondary to colorectal cancer.

RESULTS:

Ninety-one procedures were performed. In univariate analysis, an increased peritoneal cancer index was associated with decreased survival (P < .001). The presence of signet ring cells was associated to a decrease in survival from 45.8 to 12.1 months (P < .001). Microsatellite sequences instability status was the only molecular prognostic factor correlated with an increase in median disease-free survival 12.4 vs 24.9 months (P = .01). The presence of a mucinous component was associated with a decreased of survival from 51.9 to 35.1 months (P = .02).

CONCLUSIONS:

Clinical factors were affecting the survival of patients. The absence of signet ring cells and mucinous component and the presence of microsatellite sequences instability may be favorable prognostic factors.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Neoplasias Retais / Adenocarcinoma / Neoplasias do Colo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Neoplasias Retais / Adenocarcinoma / Neoplasias do Colo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article